Fiduciary Wealth Partners’s AbbVie ABBV Stock Holding History

Fiduciary Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$303K	Buy	1,160 +2	+0.2%	+$513	0.14%	41
2026 Q2	$291K	Buy	1,158 +26	+2%	+$5.59K	0.16%	51
2026 Q1	$246K	Sell	1,132 -1,008	-47%	-$224K	0.16%	50
2025 Q4	$489K	Sell	2,140 -28	-1%	-$6.38K	0.2%	42
2025 Q3	$502K	Buy	2,168 +510	+31%	+$104K	0.21%	42
2025 Q2	$308K	Buy	1,658 +503	+44%	+$93.5K	0.29%	39
2025 Q1	$242K	Buy	+1,155	New	+$225K	0.21%	32

Other funds holding ABBV

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fiduciary Wealth Partners's ABBV Position: Q3 2026 in Review

Fiduciary Wealth Partners increased its AbbVie (ABBV) stake by 0.17% in Q3 2026, buying an estimated $513 and bringing the position to 1,160 shares worth $303K. The position accounts for 0.14% of the portfolio, ranked #41.

Fiduciary Wealth Partners first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. The position peaked at $502K in Q3 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Fiduciary Wealth Partners held 1,160 shares of AbbVie worth $303K as of Q3 2026.
Fiduciary Wealth Partners bought 2 AbbVie shares in Q3 2026, an estimated $513.
AbbVie made up 0.14% of Fiduciary Wealth Partners's portfolio in Q3 2026, its #41 holding.
Fiduciary Wealth Partners first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
Fiduciary Wealth Partners's AbbVie position peaked at $502K in Q3 2025.
3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.